News Industry News Boston Scientific Announces Scheduled Presentations at Heart Rhythm Society 2015 May 11, 2015
News Conference News TCT 2014 LAA Closure Edges Out Medical Therapy for Cost-effectiveness in AF September 14, 2014
News Daily News LAA Occlusion More Cost-effective Than Both Warfarin and Dabigatran for A-fib Patients Yael L. Maxwell June 07, 2013
News Daily News ASAP Published: Watchman a Safe Option for A-fib Patients Ineligible for Warfarin Yael L. Maxwell April 12, 2013
News Daily News ASAP Publicado: Watchman es una Opción Segura para Pacientes con FA No Aptos para tomar Warfarina Yael L. Maxwell April 12, 2013
News Daily News PROTECT AF: Watchman Device Improves Quality of Life in A-fib Patients Jason Kahn February 28, 2013
News Daily News PROTECT AF: El Dispositivo Watchman Mejora la Calidad de Vida de Pacientes con Fibrilación Auricular Jason Kahn February 28, 2013
Presentation Quality-of-Life Assessment in the Randomized PROTECT AF Trial of Patients at Risk for Stroke with Nonvalvular A-fib Presenter: 147572|Oluseun Alli February 27, 2013
Presentation TCT 2012 Quality-of-Life and Cost-Effectiveness After LAA Closure Presenter: Vivek Reddy October 23, 2012